"Centrum Medyczne INTERCOR"

During the past decade, INTERCORE Medical Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "INTERCORE Medical Center" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "INTERCORE Medical Center" are "Heart Failure" (3 trials), "Advanced Breast Cancer" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Dyslipidemias" (1 trials) and "Familial Hypercholesterolemia" (1 trials). Many other conditions were trialed in "INTERCORE Medical Center" in a lesser frequency.

Most popular intervention types in "INTERCORE Medical Center" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Empagliflozin" (3 trials), "BI 456906" (1 trials), "BI 690517" (1 trials) and "Chemotherapy Drugs, Cancer" (1 trials). Other intervention names were less common.

The vast majority of trials in "INTERCORE Medical Center" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "INTERCORE Medical Center". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in INTERCORE Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in INTERCORE Medical Center, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".